1 / 32

Healthcare Quality - a Janus view

Healthcare Quality - a Janus view. Rajesh Patel BHF May 2009. Janus. In Roman mythology, Janus (or Ianus) was the god of gates, doors, doorways, beginnings and endings

rschnell
Télécharger la présentation

Healthcare Quality - a Janus view

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Healthcare Quality - a Janus view Rajesh Patel BHF May 2009

  2. Janus • In Roman mythology, Janus (or Ianus) was the god of gates, doors, doorways, beginnings and endings • Janus was usually depicted with two heads looking in opposite directions. According to a legend, he had received from the God Saturn, in reward for the hospitality received, the gift to see both future and the past.

  3. Healthcare Quality

  4. Objectives • What is quality? • Janus view of quality using HQA 2008 report results • Message • System excellence, weaknesses and cost drivers • Some suggestions on risk management • Value of HQA report and participation

  5. What is “quality” in Healthcare?

  6. Major attributes of Quality (noun) in Healthcare • Access • Transport • Benefits • Accountability • Affordability • Continuity of care • Efficacy • Effectiveness • Efficiency • Equity

  7. Quality Assurance • Definition • Anything done to measure and improve quality of care. • 3 dimensions • To define • To measure • To improve • Tools • Accreditation • Provider profiling • etc

  8. Quality (verb) Improvement & Medical Audit

  9. NCQA: Diabetes quality improvementIt is an ongoing process!

  10. Healthcare Quality: Implementation and Assessment • Structure/ standards • Process • Outputs including Outcomes

  11. Healthcare Quality Assessment

  12. Structure: Practice Guidelines • 52-55% adherance to guidelines1,2 Use of CPGs by 28 Canadian healthcare facilities 3% of respondents Use CPGs regularly (well-established CPG process/program) 12.7 Use CPGs occasionally (on an ad hoc basis) 23.3 Beginning to explore of develop CPGs 22.8 Never use CPGs 40.7 No response 0.4 • NCQA • Disease Management Network • http://www.law.utoronto.ca/healthlaw/basket/docs/BP2_financialincentives.pdf

  13. Structure: PMB • Equity & Access • 26 CDL • Iniquitous, therefore unconstitutional • Technically, not part of PMB! • DTP • Menopause • Life threatening vitamin and mineral deficiency • Always late Pathologist • Effectiveness • Interferon for MS • Efficiency • At cost, no limitation • Affordability • Without specification • Accountability Too many inconsistencies! Good intentions lost through implementation!

  14. Health quality improvement for “Industry Medical Aid Scheme” • As seen through the eye of trustee, CEO or health risk manager • HQA report • 2007 claim data • Claims paid from risk and savings benefits • Unpaid claims not included • Normalised • 2 schemes resubmitted data

  15. Medical School Humour • Physician • Knows a lot, does little • Surgeon • Knows a little, does a lot • Pathologist • Knows a lot, does a lot, always too late!

  16. Maternal Health 2005-2007 • Contraception • ppp • Above 30% • Inefficiency cost • Solutions: • Professionalism • Clinical governance • Financial incentives proposal… District Health Barometer 2007/08

  17. According to Darwin: “future” human race

  18. CAD DUR intervention to promote benefit 10% of adults

  19. Diabetes: 2005 and 2007Is there place for disease management? • What happened to cholesterol coverage? • 2005/2007 difference • Podiatry and LL amputation observation? • Intervention: In-house or CDE?

  20. Diabetes: 2005, 2007 and CDENot Case-mix adjusted! 31x 11.5x 4x(US) CDE: n =13312; 7-10% of FFS Diabetics

  21. Asthma It’s about reversibility! • SA • 4th highest asthma related death rate in the world • 1999: MSO • Peak flow for self Mx: 17% • World Asthma meeting 2001

  22. COPD:Too little, too late! ? *MAG conference 2002 Limited treatment options: What about Spiriva into the future?

  23. HIV ? *MAG conference 2002

  24. Preventative Care and the PMB • Screening is not justified when treatment is inaccessible • Prostate screening not included! • Marketing benefit • USPSTF

  25. Summary • Under-utilisation and underfunding of essential services that is available in current benefits • Avoidable expenditure is being incurred (big demand for costly latest and greatest)

  26. Janus peeped into the past!What is the view ahead?

  27. Looking forward • Structure • Benefit design: • What are the objectives? • PMB: “prevent dumping on the state” • Hospital, not “healthcare”, access achieved! • Use the needs analysis approach • Affordability level? • Accreditation • Third party: effectiveness of Managed Care can be improved • Service provision…

  28. Looking forward • Process • “expensive” PMB to cost more (investment) before it will cost less • Member access to PMB benefits • Lack of awareness of entitlement by members • PMB claims identification and assessing issues • BHF commenced engagement with schemes/administrators

  29. Looking forward • Opportunities to intervene and make a difference, together with providers of service and other stakeholders • Providers are hungry for this type of feedback! • They too have an interest in our members well being • Provider remuneration (PBR) • ?incentives/rewards and ethical considerations • Performance based reimbursement using withhold/reward

  30. Looking forward • If you don’t measure, you don’t manage! • Need for active and proactive management • Minimum reporting standards for schemes • Demographic monitoring • Public health / health status indicators (BHF 2007) • Clinical quality indicators - HQA • Utilisation indicators and report • Finance & Economic indicators • Third party processes report

  31. HQA • Section 21 Company • Established by the industry for the industry • Includes Associates • Initiative supported by BHF, CMS and Consumer Union • Ongoing development for improvement • CEO: Louis Botha lj.botha@iafrica.com

More Related